Method of health improvement in cardiovascular and nervous diseases

FIELD: medicine.

SUBSTANCE: invention concerns medicine, namely therapy and neuropathology, and concerns treatments of cardiovascular and nervous diseases. It is ensured by daily intravenously drop-by-drop introduction of physiologic saline 200 ml containing magnesium sulphate, ascorbic acid, hydrogen peroxide in a certain percentage ratio within 15 days. From the 16th day, during the following 7 days, aqueous solution 200 ml containing vitamin complex and cavinton in a certain percentage ratio is additionally introduced. Besides, from first day of treatment, Cerbrum Compositum-N is daily injected intramuscularly every second day within 21 days and 10% herbal tincture of Sophora, mistletoe and arnica taken in equal ratio and dosed 1 tablespoon at 7,12,17,21 o'clock. In addition, a suspension 5 ml containing live hen's egg per 150 ml physiologic saline is introduced once a week.

EFFECT: invention provides effective treatment of cardiovascular and nervous diseases in reduced drug loading ensured by optimum quantitative and qualitative composition, as well as developed schedule of drug introduction.

3 ex, 1 tbl

 

The invention relates to medicine, namely to the improvement of the methods of folk medicine after the diseases of cardiovascular and nervous system.

With the improvement of the methods of folk medicine uses a wide Arsenal of plant origin, as well as homeopathic remedies a wide spectrum of action.

There is a method of treatment of cardiovascular diseases with the use of a composition comprising a mixture of 30-40% alcohol tinctures of medicinal plants hawthorn (fruit or flowers), motherwort (herb), Sophora japonica (fruit), Valerian (root), Eleutherococcus senticosus (root), ziziphora Bunge or paruccini (grass), taken in a certain ratio (RU2279286 C1, 10.07.2006).

In another invention (RU2262348 C1, 20.10.2005) described a method for the treatment of vascular diseases of the brain with the use of homeopathic medicines "Cerebrum compositum and Hepar compositum", which ensures the reduction of various psychotic and non-psychotic depressive syndromes.

In the invention (EN 2163132 C1, Zakharov, 20.02.2001) described the medicinal collection for the treatment of cardiovascular diseases, which contains the hawthorn flowers, herbs, mint, mistletoe, clover, motherwort, thyme and Valerian root, burdock root, herb Rue, hops, grass dispute the Sha and lady's bedstraw, the root of Valerian and groundsel, berries, Astragalus woolly, grass treacle, the herb Arnica Montana and spring Adonis, and used the flowers of the hawthorn blood-red flowers of yellow melilot.

There is a method of healing the body (EN 2201229, Mironov, 27.03.2003 - the nearest equivalent), including intravenous solution of hydrogen peroxide and ascorbic acid, which further 2-6 times per week consists of separate sequential intravenous drip solution of magnesium sulfate at a concentration of 5-8 g/l saline solution in the amount of 190-210 ml and ascorbic acid in a 10%-aqueous solution in the amount of 280-320 ml, while the hydrogen peroxide solution is administered 1-3 times per week at a concentration of 0.04 to 0.15% in the number of 200-250 ml, and the treatment for 1-5 months. The method involves, as additional events, fees medicinal plants. However, this method is not specific to diseases of the cardiovascular and nervous system.

The present invention is a method of healing the body in diseases of the cardiovascular and nervous systems using both hydrogen peroxide and magnesium sulfate while ensuring desensitization and recovery of the organism by methods of herbal medicine.

Task resh what is fact, what method of healing the body in diseases of the cardiovascular and nervous system includes intravenous drip compositions containing magnesium sulfate and ascorbic acid in saline solution, hydrogen peroxide, oral drug collection.

The method differs in that the hydrogen peroxide, magnesium sulphate and ascorbic acid is administered in the form of a composition containing 200 ml of physiological solution:

magnesium sulfate 25% - 4,8-5,2 ml hydrogen peroxide 3% - 8,7-9,3 ml ascorbic acid, 10% - 14,5-15,5 ml, the composition is administered daily for the first 15 days. Starting from the 16th day for 7 days additionally injected intravenously for at least 1.5 hours a vitamin solution in an amount of 200 ml containing 200 ml of water: ascorbic acid 10% - 24-26 g, vitamin B6 and 2.9-3.1 g, vitamin B2 -1,95-2,05 g, nicotinic acid - 1.9 to 2.1 g, Cavinton - 4,9-5,02,

Daily for 45 days to appoint receive 10%tinctures of medicinal collection Sophora, mistletoe and Arnica, taken in equal proportions (1 tablespoon at 7, 12, 17, 21 h, and optionally, one week imposed a suspension of living matter chicken eggs in an amount of 5 ml concentration of an egg in 150 ml of physiological solution, intramuscularly in the number 10-12 injections during the first 21 days to enter the drug cerebrum compositum-Vnutrimyshecnam 2 ml a day.

The technical result of the invention is to reduce the drug load and disease prevention using non-deficient medicines and traditional medicines.

When implementing the method required to comply with the General recommendations for intravenous drugs and the dosage set by us experimentally. Below the lower range of concentrations is not observed any positive dynamics, and above the upper range there is a risk of complications. The search for the optimal individual dose should be started with low concentrations specified in patented range of concentrations. The introduction of composition containing 200 ml of physiological solution: magnesium sulfate 25% - 4,8-5,2 ml hydrogen peroxide 3% - 8,7-9,3 ml ascorbic acid, 10% - 14,5-15,5 ml, it is necessary to implement drip through slowly (up to 60 drops per minute), because you know that with the rapid introduction of solutions containing magnesium sulfate, possible respiratory depression. Ascorbic acid as an antioxidant that protects cell membranes and, in particular, lymphocytes from the damaging effects of lipid peroxidation. This is the basis of immunomodulatory effects of vitamin C, which shows itself in action at the cellular and humoral mechanisms of immunity, the migration of lymphocytes, hemotoxic.

These components of the composition are mixed immediately before the statement of the dropper. Be aware that if you cook the composition in advance, due to the fact that magnesium sulfate is necessarily present an admixture of iron (physiological solution, its content can be up to 10-6), iron ions 2+ immediately initiate the decomposition of hydrogen peroxide (Fenton reaction) and the oxidation of organic matter. This reaction will lead to the collapse of both hydrogen peroxide and ascorbic acid.

Vitamin solution for oral administration of 200 ml of water contains: ascorbic acid 10% - 24-26 g, vitamin B6 and 2.9-3.1 g, vitamin B2 - 1,95-2,05 g, nicotinic acid 1.9 to 2.1 g, Cavinton - 4,9-5,02,

The recommended preparation for holding a General tonic and desensitizing therapy decoctions drug fees carry out the traditional way.

Once a week to introduce the living substance chicken eggs in an amount of 5 ml of a suspension intramuscularly, mostly in the middle third of the outer side of the thigh (method Gagauzia). Shell siegesgesang, still warm eggs treated with alcohol. The shell is broken with a sterile spatula. Then the hole is increased by breaking from the inside with sterile forceps. The contents of the egg vystragivaetsja in sterile Cup, white and yolk stir the camping wand; then gradually added to the physiological solution (150 ml), and everything is taken to obtain a uniform color liquid (milk is yellowish). The mixture is trying to enter into a sterile syringe (5 g for adults).

As one of the possible examples, the following procedures (see table).

Patent-pending method of healing the body with cardiovascular and nervous diseases confirmed by examples, not exhaustive, however, the effectiveness of its application and other pathologies.

Example 1. Patient C-VA S. p., 75 years old, came into the office Mironov VA with complaints of weakness, shortness of breath when walking, recurrent pain in the left half of the chest, increased blood pressure up to 190-200/90-120 mmHg ECG: sinus rhythm, right, the vertical position of the EOS, the rise of the ST segment above contours at 1, 2 chest leads, negative the T wave in 3-m standard and AVF leads. Diagnosis at admission: coronary heart disease, angina and rest, atherosclerotic cardiosclerosis. Hypertension - 2 tbsp.

Was carried out following treatment: the purpose of composition containing 200 ml of physiological solution: 25% solution of magnesium sulfate - 4.8 ml; hydrogen peroxide 3% - 9 ml ascorbic acid, 10% to 15 ml of the Composition was administered intravenously, slowly, every day during the first 15 days of treatment. Starting from the 16th day of treatment for 7 days was administered vitamin solution in 200 ml of intravenous drip for at least 1.5 hours. This solution contained 200 ml of water: ascorbic acid 10% - 25 g, vitamin B6 - 3 g, vitamin B2 - 2 g, nicotinic acid, 2 g, Cavinton - 2, once a week was introduced live chicken egg in an amount of 5 ml intramuscularly in the form of a suspension. Additionally, during the first 21 days was administered cerebrum compositum-N intramuscularly with 2 ml a day. Also, the patient received a 10% tincture of medicinal collection Sophora, mistletoe and Arnica, taken in equal proportions, daily 1 tablespoon 7, 12, 17, 21 hours.

After treatment with the aforementioned method the patient noted significant improvement in well-being: HELL stabilized at values of 140/90 mm Hg, decreased frequency and intensity of pain. On the control ECG: sinus rhythm correct, the T wave bipolar 3 and AVF leads, ST-segment almost returned to the contours in the 2nd chest leads. The result of treatment was positive. Recommended to continue treatment for 6 injections of living matter chicken eggs, receive 10% tincture of Sophora, mistletoe and Arnica within 2 weeks.

Example 2. Patient in A.A., 64 years old, complained of frequent bouts of pressure increase up to 210/110 mm Hg, accompanied by pain statelocal part of the head, in the area of the left half of the chest, nausea, sometimes vomiting. On examination: skin several hypermonogenic, moist, pasty. The excess weight. ECG: sinus rhythm, right. Negative tooth T in 2 standard and AVL leads, signs of left ventricular hypertrophy. AD=160/100. Diagnosis: Hypertension 2 tbsp. patients were assigned to treatment: the introduction of composition containing 200 ml of physiological solution: 25%solution of magnesium sulfate to 5.0 ml hydrogen peroxide 3% - 8 ml ascorbic acid, 10% to 15 ml of This composition was injected intravenously very slowly for 15 days. Starting from the 16th day of treatment for 7 days was administered intravenously, for at least 1.5 hours, 200 ml of vitamin solution, the composition of which is specified in example 1. Once a week was introduced live chicken egg in an amount of 5 ml intramuscularly in the form of a suspension. During the first 21 days was administered cerebrum compositum-N, 2 ml a day, intramuscularly. The patient was prescribed a 10% tincture of medicinal collection Sophora, mistletoe and Arnica, taken in equal proportions, daily 1 tablespoon 7, 12, 17, 21 hours.

To control the admission of 1.5 months the patient is marked as positive: hypertensive crises have become more rare, the intensity of symptoms decreased significantly. Almost Prakrit who were bouts of nausea. Headaches sometimes troubling, but their severity was less easily avoided by taking "aspirin". During examination: skin-normal color, warm. Is a minor pastos. AD=140/90, pulse=74 beats per minutes ECG without significant change. To consolidate therapeutic effect to the patient recommended: 1 time a week injection of living matter chicken eggs; 4 injections of 10% solution of ascorbic acid 2 times a week; further injection of hydrogen peroxide solution at a concentration of 0.05-0.1% in the amount of 200 ml in 2-3 weeks.

Example 3. Patient 3-Eva Y.A., 35 years old, came into the office with complaints of dizziness, seizures, heart palpitations, frequent mood changes, periodic headaches, increased sweating, loss of appetite. In connection with their condition often takes sedatives (phenazepam, Relanium). Their state connected with trouble at work, setbacks in his personal life. On examination: skin is pale, cold palpation, skin redness of the face and neck. Muffled heart sounds, regular rhythm. AD=115/60, pulse=94 beats/min Diagnosis at admission: astheno-neurotic syndrome.

The patient was assigned to the following treatment: the introduction of composition containing 200 ml of physiological solution: 25% solution of magnesium sulfate 4.8 ml, hydrogen peroxide 3% - 9 is l, ascorbic acid 10% - 15 ml, intravenous drip, very slowly every day during the first 15 days of treatment. Starting from the 16th day of treatment for 7 days was additionally administered intravenously over a period of 1.5 hours, 200 ml of vitamin solution (example 1). Once a week was introduced live chicken egg quantity 5 ml intramuscularly in the form of a suspension. Assigned 10% tincture of medicinal collection Sophora, mistletoe and Arnica. A diet with restriction of salt, fat and higher-carbohydrate options. Once a week, starting with 23 days of treatment, additionally within 2 months were injected intravenously with 0.1%hydrogen peroxide solution in an amount of 200 ml After the treatment, the patient reported improvement of health: became more calm, mood, appetite, completely stopped the headaches. The patient refused to receive tranquilizers. On examination: skin-normal color, warm. AD=120/80, pulse=82 beats./min, the Effect of treatment is assessed as positive. To consolidate therapeutic effect to the patient recommended: drug cerebrum-compositum-N 2.0 ml intramuscularly every other day for the next 20 days

The approximate scheme assignments
Days from the beginning Leche is of 1234567891011-121314151617
Trackxxxxxxxxxxxxxxx
Vitamin R-R xx
Cerebrum compassus-Nxxxxxxxxx
Suspension of live in-VA eggxxx
Dosage the initial collection xxxxxxxxxxxxxxxxx

Days from start of treatment18192021222324-28293031-353637383940-45
Track
Vitamin R-Rxxxxx
Cerebrum compositum Nxx
Suspension of live in-VA egg xxxx
Drug feexxxxxxxxxxxxxxx

The method of healing the body in diseases of the cardiovascular and nervous system, including intravenous drip compositions containing magnesium sulfate and ascorbic acid in saline solution, hydrogen peroxide, oral drug collection, characterized in that
hydrogen peroxide, magnesium sulphate and ascorbic acid is administered in the form of a composition containing 200 ml of physiological solution:
magnesium sulfate 25% - 4,8-5,2 ml,
hydrogen peroxide 3% - of 8.7 and 9.3 ml,
ascorbic acid 10% - 14,5-15,5 ml, the composition is administered daily is for the first 15 days, starting from the 16th day for 7 days additionally injected intravenously for at least 1.5 h vitamin solution in an amount of 200 ml containing 200 ml of water:
ascorbic acid 10% - 24-26 g
vitamin B6 is 2.9-3.1 g,
vitamin B2 - 1,95-2,05 g
nicotinic acid is 1.9 - 2.1 g,
Cavinton - 4,9-5,02 g
daily for 45 days to appoint receive 10%tinctures of medicinal collection Sophora, mistletoe and Arnica, taken in equal proportions (1 tablespoon in 7,12,17,21 h,
additionally, once a week to introduce a suspension of living matter chicken eggs in an amount of 5 ml concentration of an egg in 150 ml of physiological solution, intramuscularly in the number 10-12 injection
and within the first 21 days to enter the drug cerebrum compositum-N intramuscularly with 2 ml a day.



 

Same patents:

FIELD: medicine.

SUBSTANCE: invention concerns medicine, namely haematology, cardiology and endocrinology, and covers correction of blood microvesicle level in arterial hypertension, dyslipidemia and impaired glucose tolerance. It is ensured by complex treatment that involves introduction of fozinopril in a dose 10 mg once a day in the morning, pioglitazone in a dose 30 mg once a day in the morning, simvastatin in a dose 40 mg in the evening in combination with graduated physical activities for therapeutic course at least 6 weeks.

EFFECT: invention provides complete normalisation of blood microvesicle level ensured by potentiation of therapeutic effect of certain components of the complex therapy; that in turn allows reducing risk of thrombotic in the given group of patients.

1 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, particularly to experimental cardiopharmacology and can be used for correction of endothelial dysfunction. It is ensured by simulation of endothelial dysfunction in experiment by intraperitoneal introduction to Wistar rats of N-nitro-L-arginine methyl ester dosed 25 mg/kg within 7 days. Thus the degree of dysfunction development is estimated by the relation of endothelium independent and endothelium dependent vasodilatation. Dysfunction is corrected by intraperitoneal introduction of preparation phosphogliv lyophilisate dosed 5.0 ml/kg and 0.5 ml/kg.

EFFECT: invention provides effective correction of endothelial dysfunction in specific experimental conditions.

2 tbl

FIELD: medicine.

SUBSTANCE: invention concerns medicine, particularly endocrinology and anesthesiology, and can be applied in pre-operation preparation of pheochromocytoma cases. It involves peroral administration of doxazozin drug in 14-21 day before operation. Initial daily drug dosage is 4 mg, by 2 mg twice per day, with further dosage increase by 2-4 mg till arterial pressure is normalised. Maximum dosage is 16 mg per day. After arterial pressure stabilisation daily doxazozin administration continues in determined therapeutic dosage. Last doxazozin take is performed in 90 minutes before narcosis in dosage of 8-12 mg.

EFFECT: prevented hypertensive crisis caused by hypercatecholaminemia during the whole operation due to timely maintenance of selective al-adrenoreceptor blockade.

1 tbl, 1 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to vascular surgery and intensive therapy, and can be used in treating the patients with acute limb ischemia. It is ensured by preoperative intravenous introduction of Perftoran during 12 hours in a dose 5 ml/kg of body weight combined with inhalation of 40-50% oxygen-enriched air mix in combination with introduction of preparations improving tissue microcirculation. It is followed with operative intervention that depending on the involvement level involves surgical approach to arteries wherein oxygenic Perftoran is introduced in amount 50 ml. Then arteries are clamped with main arteries and collaterals being excluded from blood circulation, and blood flow is restored. After the operation, during 12 h the patient takes inhalations of the oxygen-enriched air mix.

EFFECT: method allows improving clinical effectiveness of such patients, and also preventing development of postischemic syndrome due to joint introduction of oxygenic Perftoran and the oxygen-enriched air mix.

1 ex

FIELD: pharmacology.

SUBSTANCE: invention concerns novel compounds of formula (1a), formula (1b), formula (1c) and formula (1d), as well as pharmaceutical composition based on them and their application in medicine obtainment. R1-R4, G, W, X, X1, U, V, a, b are defined in the invention claim.

EFFECT: compound with antagonistic effect on vasopressin V1A receptor.

73 cl, 133 ex

FIELD: pharmacology.

SUBSTANCE: invention concerns novel compounds of formula (1a), formula (1b), formula (1c) and formula (1d), as well as pharmaceutical composition based on them and their application in medicine obtainment. R1-R4, G, W, X, X1, U, V, a, b are defined in the invention claim.

EFFECT: compound with antagonistic effect on vasopressin V1A receptor.

73 cl, 133 ex

FIELD: pharmacology.

SUBSTANCE: invention concerns compounds of formula (I) , where A is optionally substituted monocyclic aryl and heteroaryl group, B is optionally substituted monocyclic nitrogen-containing heterocyclic group, and either a) R1 is hydrogen atom and R2 is group selected out of -NH2 and optionally substituted alkinyl group, or b) R2, R1 and -NH- group with linked R1 form fragment selected out of fragments of formulae , , and , where Ra is selected out of hydrogen atom and group selected out of optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted aryl, -OR3, where R3 is independently selected out of group including hydrogen atom and lower alkyl or cycloalkyl groups, Rb is selected out of hydrogen atom and group selected out of optionally substituted alkyl or optionally substituted cycloalkyl group; application of claimed compounds in medicine obtainment for treatment of pathological states or diseases, the course of which is alleviated by antagonistic effect on adenosine receptor A2B, and pharmaceutical composition with antagonistic effect on adenosine receptor A2B.

EFFECT: compounds applicable in treatment of such diseases as asthma, bronchostenosis, allergic diseases, hypertension, atherosclerosis, reperfusion injury, myocardial ischemia, retinopathy, inflammation, gastrointestinal disorders related to cell proliferation, diabetes and/or autoimmune diseases.

26 cl, 49 ex, 2 tbl

FIELD: medicine.

SUBSTANCE: hop or hop-product is subjected to isomerisation reaction in presence of water in alkaline medium and at least one extraction, which is carried out by at least one organic solvent, selected from group of alcohols, water-containing alcohols, ketones, water-containing ketones or ethers or their mixtures or alkalised water. Reaction of isomerisation and at least one extraction is continued until obtained is extract which contains 8-prenylnaringenyl, in which (8-prenylnaringenin×100%)/(8-prenylnaringenin+6-prenylnaringenin) ratio constitutes at least 50%. By said method obtained is hop extract, which has estrogenic and anti-proliferative bioactivity. Hop extract is applied for producing medicament in which probable proliferative activity, caused by estrogenic activity of 8-prenylnaringenin, is inhibited or balanced by anti-proliferative activity of xanthogumol. Hop extract is applied for producing medicament for treatment or prevention of one of conditions, symptoms, complaints or diseases, caused by disturbance of hormonal balance of estrogenic nature.

EFFECT: invention allows realisation of said function.

25 cl, 2 tbl, 2 ex

FIELD: medicine.

SUBSTANCE: invention refers to the compound of the formula (I) , where R1 is a group of the formula and, in which R2, R3, R4, R5, R6, R7 and R8, each one independently represents a hydrogen atom or C1-6alkyl or its salt, to the method of its producing, to the method of antagonist effect on angiotensin II in the mammal, to the application of compounds of formula (I) as well as to methods of diseases prevention or treatment.

EFFECT: there are produced and provided new compounds that can be applied for prevention or treatment of disturbed circulation.

16 cl, 2 tbl, 9 ex

FIELD: medicine.

SUBSTANCE: method consists in cellular therapy. According to experimental investigation results the chosen portion of cells known for limb ischemia treatment shall be divided into two parts. One part of cells is intramuscularly injected and the other part is injected intraarterially.

EFFECT: ensuring optimal conditions for limb circulation management.

1 tbl, 1 dwg

FIELD: medicine.

SUBSTANCE: invention concerns chemical and pharmaceutical industry, particularly production of natural media with anti-inflammatory and anti-microbe effect. Mixture includes European pyrola, sidebells wintergreen and prairieweed at 2:2:6 ratio.

EFFECT: enhanced efficiency of treatment, reduced inflammatory changes, reduced duration and intensity of painful sensations, extended range of herbal medicines.

FIELD: medicine.

SUBSTANCE: invention concerns chemical and pharmaceutical industry, particularly production of natural media with anti-inflammatory and anti-microbe effect. Mixture includes European pyrola, sidebells wintergreen and prairieweed at 2:2:6 ratio.

EFFECT: enhanced efficiency of treatment, reduced inflammatory changes, reduced duration and intensity of painful sensations, extended range of herbal medicines.

FIELD: medicine.

SUBSTANCE: invention concerns chemical and pharmaceutical industry, particularly production of natural media with anti-inflammatory and anti-microbe effect. Mixture includes European pyrola, sidebells wintergreen and prairieweed at 2:2:6 ratio.

EFFECT: enhanced efficiency of treatment, reduced inflammatory changes, reduced duration and intensity of painful sensations, extended range of herbal medicines.

FIELD: medicine.

SUBSTANCE: invention concerns medicine, particularly therapy and neurology and selection of treatment tactics for chronic cerebral ischemia cases. It involves determination of electrophoretic mobility of erythrocytes. Its rise above 1.26±0.02 indicates preservation of adaptation reserves and suitability of administering adaptogens of herbal origin for activation of stress-realising body systems. Electrophoretic mobility fallen under 1.21±0.012 indicates depletion of body adaptation capacity and suitability of administering neuropeptides of stress-limiting effect.

EFFECT: enhanced treatment efficiency, reduced side effects due to taking individual features of adaptation process into account.

1 tbl, 3 ex

FIELD: veterinary.

SUBSTANCE: invention relates to veterinary, relates to medicine, which stimulates protective powers of organism, and method of secondary immunodeficiency correction with its application. Method includes injection of non-specific immunoglobulin and additional taking of alcohol tincture of equal quantities of herb and inflorescence of Echinacea purpurea, herb of Harmal common, flowers of small-leaved lime and roots of Liquorice in form of water solution 7-8% concentration in doze 1.5-2.5 ml/kg of live weight of animal during 15 days with 24 hour interval. Medicine impacts beneficially on all organs and systems of animal organism, regulates metabolism and increases resistance of organism (activation of B- and T-systems, phagocytosis), which provides correction of secondary immunodeficiencies to level of physiological norm.

EFFECT: natural origin, possibility to metabolise easily and be excreted from organism, high compatibility with other medicines, absence of sensitisation and induction of immuno-pathological reactions.

2 cl, 6 tbl, 4 ex

FIELD: veterinary.

SUBSTANCE: invention relates to veterinary, relates to medicine, which stimulates protective powers of organism, and method of secondary immunodeficiency correction with its application. Method includes injection of non-specific immunoglobulin and additional taking of alcohol tincture of equal quantities of herb and inflorescence of Echinacea purpurea, herb of Harmal common, flowers of small-leaved lime and roots of Liquorice in form of water solution 7-8% concentration in doze 1.5-2.5 ml/kg of live weight of animal during 15 days with 24 hour interval. Medicine impacts beneficially on all organs and systems of animal organism, regulates metabolism and increases resistance of organism (activation of B- and T-systems, phagocytosis), which provides correction of secondary immunodeficiencies to level of physiological norm.

EFFECT: natural origin, possibility to metabolise easily and be excreted from organism, high compatibility with other medicines, absence of sensitisation and induction of immuno-pathological reactions.

2 cl, 6 tbl, 4 ex

FIELD: veterinary.

SUBSTANCE: invention relates to veterinary, relates to medicine, which stimulates protective powers of organism, and method of secondary immunodeficiency correction with its application. Method includes injection of non-specific immunoglobulin and additional taking of alcohol tincture of equal quantities of herb and inflorescence of Echinacea purpurea, herb of Harmal common, flowers of small-leaved lime and roots of Liquorice in form of water solution 7-8% concentration in doze 1.5-2.5 ml/kg of live weight of animal during 15 days with 24 hour interval. Medicine impacts beneficially on all organs and systems of animal organism, regulates metabolism and increases resistance of organism (activation of B- and T-systems, phagocytosis), which provides correction of secondary immunodeficiencies to level of physiological norm.

EFFECT: natural origin, possibility to metabolise easily and be excreted from organism, high compatibility with other medicines, absence of sensitisation and induction of immuno-pathological reactions.

2 cl, 6 tbl, 4 ex

FIELD: medicine.

SUBSTANCE: invention concerns veterinary medicine, bioactive stimulation agent and method of secondary immunodeficiency correction applying the agent. Method involves subcutaneous injection of non-specific immunoglobulin and additional oral application of alcohol infiltration of minced herbal mix including grass and inflorescence of Echinacea purpurea, coltsfoot, harmala shrub grass and common licorice roots at equal amount in the form of aqueous solution of 7-8% concentration in the dosage of 1.5-2.0 ml per kg of live weight for 15 days at 24 hour interval. Bioactive stimulation agent renders positive effect on all animal organs and systems, adjusts metabolic processes and enhances organisms resistance (activation of B- and T-systems, phagocytosis), allowing for correction of secondary immunodeficiency to physiological standard level.

EFFECT: natural origin, easy metabolic assimilation and excretion, high compatibility with other medicines, absent sensibilisation and induction of immunopathological reactions.

2 cl, 6 tbl, 3 ex

FIELD: medicine.

SUBSTANCE: invention concerns veterinary medicine, bioactive stimulation agent and method of secondary immunodeficiency correction applying the agent. Method involves subcutaneous injection of non-specific immunoglobulin and additional oral application of alcohol infiltration of minced herbal mix including grass and inflorescence of Echinacea purpurea, coltsfoot, harmala shrub grass and common licorice roots at equal amount in the form of aqueous solution of 7-8% concentration in the dosage of 1.5-2.0 ml per kg of live weight for 15 days at 24 hour interval. Bioactive stimulation agent renders positive effect on all animal organs and systems, adjusts metabolic processes and enhances organisms resistance (activation of B- and T-systems, phagocytosis), allowing for correction of secondary immunodeficiency to physiological standard level.

EFFECT: natural origin, easy metabolic assimilation and excretion, high compatibility with other medicines, absent sensibilisation and induction of immunopathological reactions.

2 cl, 6 tbl, 3 ex

FIELD: medicine.

SUBSTANCE: invention concerns veterinary medicine, bioactive stimulation agent and method of secondary immunodeficiency correction applying the agent. Method involves subcutaneous injection of non-specific immunoglobulin and additional oral application of alcohol infiltration of minced herbal mix including grass and inflorescence of Echinacea purpurea, coltsfoot, harmala shrub grass and common licorice roots at equal amount in the form of aqueous solution of 7-8% concentration in the dosage of 1.5-2.0 ml per kg of live weight for 15 days at 24 hour interval. Bioactive stimulation agent renders positive effect on all animal organs and systems, adjusts metabolic processes and enhances organisms resistance (activation of B- and T-systems, phagocytosis), allowing for correction of secondary immunodeficiency to physiological standard level.

EFFECT: natural origin, easy metabolic assimilation and excretion, high compatibility with other medicines, absent sensibilisation and induction of immunopathological reactions.

2 cl, 6 tbl, 3 ex

FIELD: medicine.

SUBSTANCE: invention concerns chemical and pharmaceutical industry, particularly production of natural media with anti-inflammatory and anti-microbe effect. Mixture includes European pyrola, sidebells wintergreen and prairieweed at 2:2:6 ratio.

EFFECT: enhanced efficiency of treatment, reduced inflammatory changes, reduced duration and intensity of painful sensations, extended range of herbal medicines.

Up!